Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Epinote Plus 333mg/145mg Tablet CR

Prescription Icon
Prescription Required

Marketer

Neuracle Lifesciences Pvt Ltd

Salt Composition

Sodium Valproate (333mg) + Valproic Acid (145mg)

Overview Epinote Plus 333mg/145mg Tablet CR

Epileptic seizures, characterized by recurrent fits and abnormal brain activity, are effectively managed by the dual-action medication, Epinote Plus 333mg/145mg CR tablets. This formulation calms nerve activity, thereby preventing seizure episodes. Administered with food, the dosage is individually determined by your physician, potentially increasing gradually until your condition stabilizes. Therapeutic effects may take weeks to fully manifest; consistent daily use is crucial. Discontinuing treatment without medical consultation risks increased seizure frequency and potential worsening of bipolar disorder. Commonly reported side effects include nausea and tremors; less frequent reactions may involve vomiting, headaches, hepatic impairment, and upper abdominal discomfort. While most side effects are transient, persistent or bothersome symptoms require immediate medical attention. Strategies to mitigate side effects exist. Prior to commencing treatment, disclose any pre-existing kidney or liver disease, meningitis, depression, or suicidal ideation. Comprehensive medication disclosure is essential, including contraceptive use, as interactions are possible. While use during pregnancy or breastfeeding necessitates careful consideration and potential dosage adjustments, it remains a possibility if deemed medically necessary. Avoid operating vehicles if drowsiness or dizziness occurs. Regular blood tests monitor therapeutic response. Alcohol consumption should be avoided as it may exacerbate side effects. Weight gain is a potential consequence; maintaining a balanced diet, limiting high-calorie snacks, and regular physical activity are recommended. Report any unusual mood shifts, new or worsening depression, or suicidal thoughts or behaviors to your physician immediately.

Uses of Epinote Plus 333mg/145mg Tablet CR

Seizure disorder

Major Benefits of Epinote Plus 333mg/145mg Tablet CR:

Follow your doctor's instructions precisely regarding the dosage and length of treatment for this medication. Ingest the Epinote Plus 333mg/145mg Tablet CR whole; do not fragment or chew it. Administer this medication with a meal.

Common Side effects of Epinote Plus 333mg/145mg Tablet CR:

  • Nausea
  • Tremors

How to use Epinote Plus 333mg/145mg Tablet CR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Epinote Plus 333mg/145mg Controlled-Release tablets with a meal.

How Epinote Plus 333mg/145mg Tablet CR works:

The extended-release tablet, Epinote Plus 333mg/145mg CR, contains a dual anticonvulsant formulation of valproic acid and sodium valproate.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Epinote Plus 333mg/145mg CR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Epinote Plus tablets (333mg/145mg) pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Epinote Plus tablets (333mg/145mg) are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.

DrivingDrivingUNSAFE

Taking Epinote Plus 333mg/145mg Controlled-Release tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Epinote Plus 333mg/145mg CR tablets appear safe for individuals with kidney conditions. Existing evidence indicates dose modification may be unnecessary, but this is based on limited information. Always seek medical advice. Discuss any pre-existing kidney disease with your physician.

LiverLiverCAUTION

Individuals with liver impairment should use Epinote Plus 333mg/145mg CR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Epinote Plus 333mg/145mg CR tablets are unsuitable for patients experiencing severe or active liver disease.

What if you forget to take Epinote Plus 333mg/145mg Tablet CR :

Should you forget to take your Epinote Plus 333mg/145mg CR tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Epinote Plus 333mg/145mg Tablet CR

LabelValue
Developing Habits No.
Treatment Category Central Nervous System (CNS) Neurology

FAQs on Epinote Plus 333mg/145mg Tablet CR

Epinote Plus 333mg/145mg CR Tablets may cause drowsiness. Refrain from driving, operating machinery, or engaging in hazardous activities. Report any drowsiness to your doctor.
Avoid alcohol while taking Epinote Plus 333mg/145mg Tablet CR, as it may worsen side effects.
Continue taking Epinote Plus 333mg/145mg Tablet CR as prescribed. Abruptly stopping this medication may worsen your symptoms. Contact your doctor if you experience any problems while taking it.
Increasing your dosage beyond the recommended amount won't necessarily improve results; it could significantly increase your risk of adverse reactions and toxicity. If your symptoms persist or worsen despite taking the recommended dose, consult your physician.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Epinote Plus 333mg/145mg ...
80
MRP 98
18% off